LANGHORNE, PA — NEXGEL, Inc. (NASDAQ: NXGL) has reported a remarkable third quarter in 2024, achieving a record revenue of $2.94 million. This represents a 141% increase from the same …| MyChesCo
MALVERN, PA — Annovis Bio Inc. (NYSE: ANVS) has announced its financial results for the second quarter ending June 30, 2024, along with significant business updates. The company highlighted positive …| MyChesCo
LANGHORNE, PA — NEXGEL, Inc. (NASDAQ: NXGL) reported record revenue of $1.44 million for the second quarter of 2024, representing a 23.4% year-over-year increase. The company’s growth was driven significantly …| MyChesCo